dihydroergotoxine has been researched along with Substance-Withdrawal-Syndrome* in 2 studies
1 trial(s) available for dihydroergotoxine and Substance-Withdrawal-Syndrome
| Article | Year |
|---|---|
Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
A compound of ergot alkaloids (Hydergine-Sandoz) or placebo was given to sixty elderly nursing home patients with non-psychotic organic brain syndrome. Subsequent to 12 weeks of treatment, the mean serum prolactin of the drug was significantly lower than that of the placebo group. No correlation was found between changes in prolactin and changes in behavior using Sandoz Assessment of Clinical Status Rating Form-Geriatric [SCAG]. It may be that a higher dose of Hydergine with an accompanying greater drop in prolactin would be required to observe this effect. Topics: Aged; Dementia; Dihydroergotoxine; Female; Humans; Male; Prolactin; Substance Withdrawal Syndrome | 1979 |
1 other study(ies) available for dihydroergotoxine and Substance-Withdrawal-Syndrome
| Article | Year |
|---|---|
Influence of nootropic drugs on drinking behaviour in ethanol-preferring mice and ethanol-induced increase of seizure susceptibility.
The influence of several nootropic drugs (piracetam, pyritinol, meclofenoxat, methylglucamine orotate (MGO) and dihydroergotoxine (DHET) on both the ethanol preference and the enhanced seizure susceptibility after a single dose of ethanol was studied. Piracetam, MGO and DHET reduce the ethanol drinking in ethanol-preferring mice. The enhanced seizure susceptibility after a single dose of ethanol was abolished by piracetam and MGO. Topics: Alcohol Drinking; Alcoholism; Animals; Dihydroergotoxine; Ethanol; Male; Meglumine; Mice; Mice, Inbred ICR; Orotic Acid; Piracetam; Seizures; Substance Withdrawal Syndrome; Synapses; Trapidil | 1985 |